Biomarkers of Multiorgan Failure in COVID-19: A Predictive Framework for Disease Severity and Clinical Outcomes
Saudi Medical Journal · 2026
DOI: 10.15537/1658-3175.1004 ↗Kurz gefasst
Fachartikel in der Zeitschrift Saudi Medical Journal, 2026. Verfasst von Wesam A Nasif und 3 weiteren Autor:innen. Beteiligte Einrichtung: Biochemistry Department, College of Medicine, Umm Al-Qura University, Makkah, Kingdom of Saudi Arabia. Hauptthemen laut MEDLINE: Multiple Organ Failure, COVID-19. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Objective
To investigate the predictive value of inflammatory, liver, renal, and cardiac biomarkers in relation to the progression of multiorgan failure (MOF) in COVID-19 patients. A primary goal was to identify which of these markers served as the most discriminative predictors of disease severity.
Methods
A retrospective cohort study was carried out between December 2020 and February 2023 to collect data from 1,803 COVID-19 patients from data records in different hospitals in Makkah, Saudi Arabia. The ROC curve analysis evaluated the diagnostic and predictive performance of selected biomarkers.
Results
Inflammatory markers such as CRP and D-dimer were evaluated, but ferritin showed only a moderate discriminatory ability for disease severity with moderate predictive value (AUC 0.621). Liver enzymes, especially AST (aspartate aminotransferase), and ALT (alanine aminotransferase), emerged as strong MOF predictors, with AST achieving an AUC of 1.000, indicating perfect sensitivity and specificity as a predictor. Renal markers like creatinine and BUN showed limited predictive power. Among cardiac biomarkers, LDH (lactate dehydrogenase), showing a robust predictive capability for MOF, demonstrated high predictive capability (AUC 0.969), and CK also performed well.
Conclusion
The AST and LDH were identified as the most reliable predictors of MOF in COVID-19 patients. These findings emphasize the importance of biomarker profiling in clinical risk assessment and early intervention. Liver and cardiac markers should be prioritized in evaluating severe COVID-19 cases to support better patient management and outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Biochemistry Department, College of Medicine, Umm Al-Qura University, Makkah, Kingdom of Saudi Arabia.
- Molecular Biology Department, Faculty of Biotechnology, Sadat City University, Sadat City, Egypt.
- Pathology Department, College of Medicine, Umm Al-Qura University, Makkah, Kingdom of Saudi Arabia.
ORCID-Profile: Wesam A Nasif, Mohammed H Mukhtar, Mohammad Althubiti, Abeer Shaker El Moursy Ali
Zitieren
APA
Nasif, W. A., Mukhtar, M. H., Althubiti, M., & Ali, A. S. E. M. (2026). Biomarkers of Multiorgan Failure in COVID-19: A Predictive Framework for Disease Severity and Clinical Outcomes. Saudi Medical Journal. https://doi.org/10.15537/1658-3175.1004
Vancouver
Nasif WA, Mukhtar MH, Althubiti M, Ali ASEM. Biomarkers of Multiorgan Failure in COVID-19: A Predictive Framework for Disease Severity and Clinical Outcomes. Saudi Medical Journal. 2026. doi:10.15537/1658-3175.1004
BibTeX
@article{Nasif2026,
author = {Nasif, Wesam A and Mukhtar, Mohammed H and Althubiti, Mohammad and Ali, Abeer Shaker El Moursy},
title = {Biomarkers of Multiorgan Failure in COVID-19: A Predictive Framework for Disease Severity and Clinical Outcomes},
journal = {Saudi Medical Journal},
year = {2026},
doi = {10.15537/1658-3175.1004}
}
EUVIMED